Kerstin Gillespie
Family · Austin, TXNPI 1932680055
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,790 and has fallen 97.8% since, to $39 in 2025.
Across 154 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$519
- Biohaven Pharmaceuticals, Inc.$266
- Amgen$265
- Biogen$244
- Novartis$236
- AstraZeneca$155
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,843100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $519 |
| Biohaven Pharmaceuticals, Inc. | 20 | $266 |
| Amgen | 15 | $265 |
| Biogen | 13 | $244 |
| Novartis | 17 | $236 |
| AstraZeneca(2 entities) | 3 | $155 |
| Jazz Pharmaceuticals Inc. | 8 | $151 |
| GSK | 2 | $138 |
| Teleflex LLC | 1 | $78 |
| Acadia Pharmaceuticals Inc | 3 | $71 |
| Sanofi | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Neurelis, Inc. | 2 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Johnson & Johnson(2 entities) | 2 | $50 |
| Lundbeck LLC | 2 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Avion Pharmaceuticals | 1 | $42 |
| Lilly USA, LLC | 2 | $41 |
| Tanabe Pharma America, Inc. | 2 | $38 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| SK Life Science, Inc. | 1 | $27 |
| Mayne Pharma Commercial LLC | 6 | $26 |
| Myovant Sciences Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Apria Healthcare LLC | 1 | $18 |
| Adamas Pharmaceuticals, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,843 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Austin
- Monique MulvanyAustin$142K
- Barry HughesAustin$51K
- Eric PerezAustin$42K
- Chelsea CrillyAustin$36K
- Alexandra RossiAustin$35K
- Angelina DetmersAustin$33K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.